Back to search

United Kingdom· GB-APID-35639411000001103

Lymphoseek 50microgram kit for radiopharmaceutical preparation

A medicinal product containing tilmanocept, registered in United Kingdom by Norgine Pharmaceuticals Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLymphoseek 50microgram kit for radiop…ATC—REGISTER NO.GB-APID-3563941100000…PACKS LISTED1CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tilmanocept
Manufacturer
Norgine Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5012748005914

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9a8af75-5dc8-4778-8908-388ae392bdd0
GET /v1/drugs/f9a8af75-5dc8-4778-8908-388ae392bdd0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "35639411000001103",
  "desc": "Lymphoseek 50microgram kit for radiopharmaceutical preparation (Norgine Pharmaceuticals Ltd)",
  "form": "Kit for radiopharmaceutical preparation",
  "vpid": "35639211000001102",
  "source": "dmd",
  "vtm_id": "39338911000001104",
  "strength": "50 microgram",
  "substance": "Tilmanocept",
  "ingredient": "Tilmanocept",
  "supplier_code": "2079801000001106"
}

See everything about tilmanocept.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.